Francesco Manetti

Francesco Manetti

Auto-generated profile, based on publicly available information

Francesco Manetti

Department of Physics, Politecnico di Milano, Milan, Italy

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2023 in Science Advances
Verified
Journal Article
Open access
Arianna BresciArianna Bresci
Arianna Bresci
Jeong Hee KimJeong Hee Kim
Jeong Hee Kim
SGSilvia Ghislanzoni
Silvia Ghislanzoni
FMFrancesco Manetti
Francesco Manetti
LWLintong Wu
Lintong Wu
Dario PolliDario Polli
Dario Polli
Anticancer therapy screening in vitro identifies additional treatments and improves clinical outcomes. Systematically, although most tested cells respond to cues with apoptosis, an appreciable portion enters a senescent state, a critical condition potentially driving tumor resistance and relapse. Conventional screening protocols would strongly benefit from prompt identification and monitoring of therapy-induced senescent (TIS) cells in their native form. We combined complementary all-optical, label-free, and quantitative microscopy techniques, based on coherent Raman scattering, multiphoton absorption, and interferometry, to explore the early onset and progression of this phenotype, which has been understudied in unperturbed conditions. We identified TIS manifestations as early as 24 hours following treatment, consisting of substantial mitochondrial rearrangement and increase of volume and dry mass, followed by accumulation of lipid vesicles starting at 72 hours. This work holds the potential to affect anticancer treatment research, by offering a label-free, rapid, and accurate method to identify initial TIS in tumor cells.

15 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
DMDeborah Mesa
Deborah Mesa
EBElisa Barbieri
Elisa Barbieri
ARAndrea Raimondi
Andrea Raimondi
SFStefano Freddi
Stefano Freddi
GMGiorgia Miloro
Giorgia Miloro
SSSara Sigismund
Sara Sigismund
One open question in the biology of growth factor receptors is how a quantitative input (i.e., ligand concentration) is decoded by the cell to produce specific response(s). Here, we show that an EGFR endocytic mechanism, non-clathrin endocytosis (NCE), which is activated only at high ligand concentrations and targets receptor to degradation, requires a tripartite organelle platform involving the plasma membrane (PM), endoplasmic reticulum (ER) and mitochondria. At these contact sites, EGFR-dependent, ER-generated Ca2+ oscillations are sensed by mitochondria, leading to increased metabolism and ATP production. Locally released ATP is required for cortical actin remodeling and EGFR-NCE vesicle fission. The same biochemical circuitry is also needed for an effector function of EGFR, i.e., collective motility. The multiorganelle signaling platform herein described mediates direct communication between EGFR signaling and mitochondrial metabolism, and is predicted to have a broad impact on cell physiology as it is activated by another growth factor receptor, HGFR/MET.

23 May 2025 in Science Advances
Verified
Journal Article
Open access
GMGiulia Marotta
Giulia Marotta
DODaniela Osti
Daniela Osti
EZElena Zaccheroni
Elena Zaccheroni
BCBrunella Costanza
Brunella Costanza
SFStefania Faletti
Stefania Faletti
GPGiuliana Pelicci
Giuliana Pelicci
Lysine-specific histone demethylase 1A (LSD1) is an epigenetic regulator involved in various biological processes, including metabolic pathways. We demonstrated the therapeutic potential of its pharmacological inhibition in glioblastoma using DDP_38003 (LSD1i), which selectively targets tumor-initiating cells (TICs) by hampering their adaptability to stress. Through biological, metabolic, and omic approaches, we now show that LSD1i acts as an endoplasmic reticulum (ER) stressor, activating the integrated stress response and altering mitochondrial structure and function. These effects impair TICs’ oxidative metabolism and generate reactive oxygen species, further amplifying cellular stress. LSD1i also impairs TICs’ glycolytic activity, causing their metabolic decline. TICs with enhanced glycolysis benefit from LSD1-directed therapy. Conversely, metabolically silent TICs mantain ER and mitochondrial homeostasis, adapting to stress conditions, including LSD1i treatment. A dropout short hairpin RNA screening identifies postglycosylphosphatidylinositol attachment to proteins inositol deacylase 1 (PGAP1) as a mediator of resistance to LSD1i. Disruptions in ER and mitochondrial balance holds promise for improving LSD1-targeted therapy efficacy and overcoming treatment resistance.

1 January 2022
Verified
Conference Paper
Closed access
PDF file
Arianna BresciArianna Bresci
Arianna Bresci
FMFrancesco Manetti
Francesco Manetti
SGSilvia Ghislanzoni
Silvia Ghislanzoni
BTBenedetta Talone
Benedetta Talone
FVFederico Vernuccio
Federico Vernuccio
Dario PolliDario Polli
Dario Polli
We introduce label-free multimodal nonlinear optical microscopy, based on different coherent Raman and multi-photon ultrafast light-matter interactions, as a noninvasive, quantitative and chemically selective tool to assess chemotherapy-induced senescence in human cancer cells.